This enrichment could potentially augment the tumor infiltration of CD4 + lymphocytes, alongside activated subsets of CD4 cells expressing KI67 + and CD69 + markers throughout the course of radiation therapy (Sims et al., 2021). This evidence concerns the gene MKI67 and neoplasm.